Reata Pharma (RETA) December option implied volatility at 230

Reata Pharma (NASDAQ: RETA) December call option implied volatility is at 230, January is at 150; compared to its 52-range of 51 to 304 after the FDA posted the documents ahead of an advisory committee meeting for (RETA) kidney disease treatment. Call put ratio 1.5 calls to 1 put.

You May Also Be Interested In

• Skechers USA (SKX) August 55 puts active
• AutoNation (AN) call put ratio 1 call to 2.4 puts into quarter results and outlook
• Colgate-Palmolive (CL) April weekly option implied volatility into quarter results